Pivotal trial of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow-up
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Clinical Research
Profound Medical is committed to research, innovation, improving procedure efficiency and saving lives. We are dedicated to changing the standard of care through quality clinical evidence, working in close partnership with clinicians, physicians, hospitals, and professional associations.
Featured Presentations
Prostate Cancer Ablation Using MRI-Guided Transurethral Ultrasound (TULSA-PRO): How I Do it?
Ram A. Pathak, MD
Klotz et al, Focal Therapy Society Annual Meeting 2023
Featured Publications
Clinical Publications
106734B